Ahyperplastic reaction of the arterial wall currently limits the long-term success of many contemporary interventional or operative approaches to the treatment of vascular disease. Although angioplasty or atherectomy performed by balloons, lasers, or rotational devices yields satisfactory initial enlargements in luminal caliber, 20% to 50% of percutaneous transluminal coronary angioplasty (PTCA) sites narrow again over a period of months due to the intimal thickening response known as restenosis.1-3 A similar process produces anastomotic narrowing that can complicate aortocoronary bypass grafts and small-caliber vascular prostheses.4 '5 Our current understanding of the pathophysiology of restenosis is incomplete as we cannot explain certain important clinical features such as the time lag between injury and restenosis. Thrombosis, often invoked as a cause of smooth muscle cell proliferation, wanes well before intimal thickening peaks, usually some months after initial dilatation.6-8 Prolonged antithrombotic therapy does not eliminate restenosis after PTCA.9 A number of laboratories have probed the cellular mechanisms of the arterial response to balloon injury to expand our understanding of this process. These valuable studies have described the morphology, kinetics, and aspects of the control of the hyperplastic response following various types of injury to rat arteries, with particular focus on cell proliferation and the expression of growth-related genes.5 '10-13 Our laboratory has a special interest in the roles of inflammation and of leukocytes in vascular diseases. In their basal or resting state, vascular endothelium and smooth muscle cells do not generally exhibit proinflammatory properties. However, when exposed to certain stimuli, vascular wall cells can express functions such as production of inflammatory mediators or of cell surface molecules that enhance leukocyte adhesion, processes we refer to here as "activation." For example, balloon injury induces expression in the vessel wall of the early response genes JE and KC, which encode inflammatory cytokines capable of stimulating monocytes or polymor-Tanaka et al Cell Activation After Balloon Injury 1789 phonuclear leukocytes. 13 When activated, intrinsic vascular wall cells and infiltrating leukocytes can elaborate these mediators and others, including interleukin (IL)-1, tumor necrosis factor (TNF), IL-6, IL-8, and macrophage-colony stimulating factor (M-CSF).14 Such cytokines might contribute to the vessel's response to injury, for example, by recruiting and activating leukocytes and inducing secondary gene expression by vascular cells.14 Previous studies of balloon injury have not examined in depth the inflammatory aspect of arterial cell activation.
This study tested the hypothesis that balloon dilatation of arteries can induce certain inflammatory functions of vascular cells and leukocytes and that such activation can continue even after the acute phase of injury. We used local expression of cytokineinducible activation markers, vascular cellular adhesion molecule-1 (VCAM-1),15-17 intercellular adhesion molecule-1 (ICAM-1),18 and class II major histocompatibility (MHC) antigen on vascular cells19.20 and leukocytes to assess cellular activation following balloon withdrawal injury to the rabbit aorta.
Methods

Animals and Surgical Procedure
This study used New Zealand White pasteurella-free rabbits (Millbrook Farms, Amherst, Mass) that weighed approximately 3 kg at the time of surgery and were fed normal rabbit chow ad libitum throughout the study. The animals were anesthetized with 35 mg/kg ketamine and 7 mg/kg xylazine IM. A longitudinal incision in the right groin region provided access to the femoral artery. After systemic heparinization (1 mg/kg), a Fogarty 3F balloon catheter was introduced into the abdominal aorta through the superficial femoral artery to 10 cm beyond the arteriotomy. The balloon was inflated with approximately 1 mL of saline (to provide moderate resistance) and withdrawn 2.0 cm twice (Fig 1, left) . The superficial femoral artery was then repaired with 8-0 polypropylene interrupted sutures to maintain an arterial flow to the right lower extremity. All (Fig 1, right) , and the infrarenal aorta was immediately excised and placed in Dulbecco's phosphate-buffered saline (PBS), and the adventitia was gently trimmed. A 1-cm longitudinal strip that spanned the border between uninjured and injured aorta, as defined by Evans blue staining, was prepared for immunohistochemical evaluation by snap-freezing in isopentane cooled in liquid nitrogen (Fig 1, right) . This analysis of longitudinal rather than cross sections permits inclusion of uninjured tissue on each slide as an internal control to aid direct comparisons and avoid day-to-day or slide-to-slide variations in immunohistochemical reactions. We exercised care to select regions of the injured zone for the longitudinal analysis that did not encompass zones of endothelial regrowth from aortic branches, easily detectable as areas within the injured zone that excluded Evans blue (Fig 1, right) biotin peroxidase complex (Vectastatin ABC kit, PK 6100, Vector Laboratories, Burlingame, Calif). Antibody binding was visualized with 3-amino-9-ethyl carbazole (AEC, Sigma Chemical). For bromodeoxyuridine labeling, sections were incubated in 2 mol/L HCl at 370C for 10 minutes to denature DNA before the addition of the primary antibody. Sections were counterstained with Gill's hematoxylin. Omission of primary antibodies, and the staining with type-and classmatched irrelevant immunoglobulin served as a negative control for each antibody.
Double Immunohistochemical Analysis
To confirm the expression of the VCAM-1 on the endothelial cells healing the injured area, we performed double immunohistochemistry. After staining for VCAM-1 using peroxidase ABC method described above (yielding a red peroxidase reaction product), sections were washed in PBS for 5 minutes, and avidinbiotin complex from the first step was blocked by incubating sections with an excess of avidin and biotin (Avidin-Biotin blocking kit, Vector Laboratories). After the application of the primary antibody against vWf at 40C overnight, sections were incubated with biotinylated horse anti-goat antibody for 45 minutes at room temperature. Sections were then incubated in alkaline phosphatase avidin-biotin complex (Vecstatin ABC kit, AK-5000, Vector Laboratories) and visualized using Fast Blue (Sigma Chemical), an alkaline phosphate substrate that produced a blue product. Sections were counterstained with methyl green. Double-stained cells showed mixtures of red (VCAM-1) and blue (vWf) tones.
Results
Expression ofActivation Markers Fig 2, second panel, left) . Few nuclei in normal portions of the rabbit aorta incorporated bromodeoxyuridine (Fig 2, bottom, left) .
Expression ofActivation Markers by Cells in the Aorta 2 Days After Injury
We observed no intimal thickening at 2 days after injury (Fig 2 and Fig 3, left) . At this time, we noted coverage of a small area near the border zone of injury with regenerating endothelial cells (Fig 2, bottom two  panels) . This degree of endothelial regeneration at 48 hours is not inconsistent with that observed in certain other studies, albeit assessed with other techniques and with some differences in the types of injuries used. [30] [31] [32] We identified as regenerated endothelium luminal cells that stained both for bromodeoxyuridine in a nuclear pattern and for endothelial markers (vWf in a cytoplasmic granules characteristic for endothelium or BS II lectin binding, see below). These cells expressed high levels of VCAM-1 and ICAM-1 (Fig 2, top, and Fig 3,  left) . In similar regions, we occasionally observed T-lymphocytes (L11/135' cells) or isolated mononuclear phagocytes (RAM-11+ cells) on the surface of regenerated endothelial cells or on the denuded luminal surface in unhealed areas (not shown). These leukocytes were too sparse to permit meaningful quantitation.
Expression ofActivation Markers by Cells in the Aorta S Days After Injury
The thickened intima contained one to three layers of neointimal cells 5 days after injury (Fig 3, right) . Almost all of these cells had undergone division since the injury (ie, were labeled with bromodeoxyuridine during the continuous infusion; Fig 4) . In addition to the expected smooth muscle cells (HHF-35+), the developing neointima contained some T-lymphocytes, macrophages, and class II MHC-bearing cells (not shown). Intimal healing by recovering with endothelial cells (vWf+) extended further toward the center of injured area than at 2 days after injury (compare Fig 2 with Fig 4) . The regenerating endothelial cells expressed VCAM-1, ICAM-1, and class II MHC antigen at much higher levels than on endothelium overlying uninjured areas on the same sections (Fig 5) . However, endothelial cells recovering the portion of the injured area just at the border zone expressed lower levels of VCAM-1 than cells at the same region had at 2 days after injury (compare Fig 2  with Fig 4) . Expression of VCAM-1 thus appeared to follow the leading edge of endothelial regeneration. In contrast, the regenerated endothelium expressed ICAM-1 and class II MHC uniformly at this time point.
These results were consistent in all four animals studied at 5 days after injury.
Expression ofActivation Markers by Cells in the Aorta 10 Days After Injury
At 10 days after injury, the neointima consisted of 5 to 15 layers of smooth muscle cells (Fig 6) , many of which had undergone division during the first 7 days after injury as determined by bromodeoxyuridine incorporation (Fig 7) . Endothelial cells that covered the injured area close to the margin between the uninjured and injured areas displayed much lower VCAM-1 expression than at 2 or even 5 days after injury. Only occasional endothelial cells in this region stained for VCAM-1, but endothelium in the same region still expressed high levels of ICAM-1 (Fig 8) . Luminal cells at the leading area of the endothelial healing (vWf+ and/or BS II+) stained intensely for VCAM-1. At this time after injury, neointimal smooth muscle cells also expressed ICAM-1 (Fig 6) . At earlier times after injury, or in uninjured vessels, rabbit smooth muscle cells express little or no ICAM-1. The expanding neointima at 10 days after injury still contained some T-lymphocytes and macrophages. However, some cells that bore no leukocyte markers expressed class II MHC, suggesting that as in atherosclerotic arteries, smooth muscle cells in balloon-injured vessels can also express histocompatibility antigens (Fig 7) .
Expression ofActivation Markers by Cells in the Aorta 30 Days After Injury
At 30 days after injury, Evans blue still stained part of the injured zone, except in one of six animals studied at this time, which had complete healing of the injured aorta as indicated by exclusion of Evans blue. The neointima consisted of many layers of smooth muscle cells, in places yielding an intimal thickness equal to that of the media. Reendothelialization was much more extensive than at 10 days after ballooning.
At 30 days after injury, Evans blue staining showed complete reendothelialization of the injured zone in one of six animals. In the five animals with incomplete endothelial healing 30 days after the injury, endothelial cells at the leading edge of recoverage still expressed high levels of both VCAM-1 (Fig 9, top) and ICAM-1 (Fig 9, middle) . Smooth muscle cells in the neointima continued to display increased ICAM-1 but more limited in extent than at 5 or 10 days after injury, being limited to the superficial layers just beneath the leading edge of endothelial recoverage (Fig 9, middle) . Interestingly, at 30 days after injury, some endothelial cells at the leading edge of recoverage and numerous smooth muscle cells in the healing neointima express class II MHC product (Fig 9, bottom) . Although we consistently observed activation of cells toward the center of the ballooned area at 30 days after injury (Fig 9), (Fig 10) . Similarly, double immunohistochemical staining for ICAM-1 and a-actin confirmed the identity of the ICAM-1-positive neointimal cells seen after 10 days as smooth muscle (not shown). Experiments on balloon injury to normal vessels have already contributed a good deal in this regard. Such studies have revealed that migration and proliferation of smooth muscle cells and accumulation of extracellular matrix materials help to form the thickened intima.5 Balloon injury of arteries augments the local expression of a number of proto-oncogenes and growth factors, although the pathophysiologic roles of the products of many of these genes remain uncertain.5 [10] [11] [12] [13] Studies on a particularly well-characterized preparation, the rat carotid artery, have implicated platelet products such as PDGF in the early migratory response of smooth muscle cells. 34, 35 Antibody neutralization studies implicate basic fibroblast growth factor as a mediator of the initial wave of smooth muscle cell replication within the injured tunica media of the rat carotid artery.36'37 Al- though much smooth muscle cell proliferation occurs within the first week following arterial injury, some replication continues for up to 4 weeks.5 '38 The mechanisms that signal this ongoing proliferation of smooth muscle cells within the expanding intima and that control the expression of extracellular matrix products remain uncertain. Clinical studies indicate that the bulk of intimal thickening following coronary angioplasty does not occur immediately but usually develops over several months following the initial injury.39 '40 Thus, although we are beginning to understand some of the early mechanisms of intimal thickening in injured arteries, we lack understanding of the cell biology of the latter and equally important phases of this process.
Discussion
This study used a novel approach to gauge the activation of vascular cells and leukocytes within the arterial wall following balloon withdrawal injury. Our results demonstrate sustained activation of vascular cells and leukocytes continuing up to 30 days after injury. We also demonstrate that activation of the pears to advance in a wave from the border of injury, as assessed by expression of the inducible cell surface molecule VCAM-1. This finding establishes spatial heterogeneity of activation in regenerating endothelium following balloon injury. Our analysis deliberately focused on endothelial healing from the uninjured zone of the aorta, and thus we cannot comment on activation of regenerating endothelium derived from aortic branches (Fig 1) . We likewise cannot exclude that some of the endothelial regeneration in the zone we analyzed derived from microscopic islands of endothelium remaining due to incomplete denudation. However, the homogeneous uptake of Evans blue in the areas of injury selected for analysis indicates that little endothelium remained after the balloon passages. Interestingly, nascent atherosclerotic lesions in rabbits also show increased VCAM expression focally in endothelial cells in the "shoulder," or presumable "leading edge" of this type of vascular lesion, as well. 16 
